← Back to directory

Vincent J. Gnanapragasam

Researcher Next ID · RN-027754

Researcher · Medicine

University of Cambridge

Cambridge, Portugal

Not currently recruitingFunding unknown
Works count
312
Citation count
25,141
H-index
65
i10-index
173

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Prostate Cancer Diagnosis and Treatment
Prostate Cancer Treatment and Research
Cancer Genomics and Diagnostics
Bladder and Urothelial Cancer Treatments
Global Cancer Incidence and Screening

Publications

  • Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

    New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2214122

  • Mapping single-cell transcriptomes in the intra-tumoral and associated territories of kidney cancer

    Cancer Cell · 2022 · https://doi.org/10.1016/j.ccell.2022.11.001

  • Resolving the immune landscape of human prostate at a single-cell level in health and cancer

    Cell Reports · 2021 · 10.1016/j.celrep.2021.110132

  • Extensive heterogeneity in somatic mutation and selection in the human bladder

    Science · 2020 · 10.1126/science.aba8347

  • Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received

    European Urology · 2019 · 10.1016/j.eururo.2019.10.030

  • Ten-year Mortality, Disease Progression, and Treatment-related Side Effects in Men with Localised Prostate Cancer from the ProtecT Randomised Controlled Trial According to Treatment Received

    European Urology · 2019 · 10.1016/j.eururo.2019.10.030

  • Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets

    Nature Genetics · 2018 · https://doi.org/10.1038/s41588-018-0086-z

  • Mutational signatures of ionizing radiation in second malignancies

    Nature Communications · 2016 · 10.1038/ncomms12605

  • Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition

    Nature · 2016 · https://doi.org/10.1038/nature19353

  • Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study

    EBioMedicine · 2015 · 10.1016/j.ebiom.2015.07.017

  • Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer

    Nature Communications · 2015 · 10.1038/ncomms7605

  • Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

    Nature Genetics · 2015 · https://doi.org/10.1038/ng.3221

  • Defining the learning curve for multiparametric magnetic resonance imaging ( MRI ) of the prostate using MRI ‐transrectal ultrasonography ( TRUS ) fusion‐guided transperineal prostate biopsies as a validation tool

    British Journal of Urology · 2014 · 10.1111/bju.12892

  • Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the G insburg S tudy G roup for E nhanced P rostate D iagnostics

    British Journal of Urology · 2013 · 10.1111/bju.12132

  • Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development

    Oncogene · 2003 · 10.1038/sj.onc.1206342

  • Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development

    Oncogene · 2003 · 10.1038/sj.onc.1206342

  • Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer

    British Journal of Cancer · 2001 · 10.1054/bjoc.2001.2179

Current projects

    No projects listed.